Bell Ceremonies

Natera Rings the Nasdaq Stock Market Opening Bell

Published

Natera (Nasdaq: NTRA), a global leader in cell-free DNA and precision medicine, visits the Nasdaq MarketSite in Times Square. The event marks Natera’s 10th year as a publicly traded company. 

Natera specializes in personalized diagnostics that help improve outcomes in three core areas: cancer care, women’s health, and organ health. Its mission is to transform the management of disease worldwide.

In honor of this occasion, Steve Chapman, CEO at Natera, rings the Opening Bell.